EYPT
EyePoint, Inc. Common Stock
Nasdaq · usd
EyePoint, Inc. Common Stock (EYPT) trades at $0.3700 (-8.53%) as of 2:33:11 PM EDT on Oct 26, 2026, -89.64% over the past month. Market cap is $34.87M, with 5.4 days to cover in short interest.
Stock performance
How EyePoint, Inc. Common Stock (EYPT) stock has performed from one day to one year, with its 52-week range.
- 1D
- -7.32%
- 1W
- -14.80%
- 1M
- -89.64%
- YTD
- -97.95%
- 1Y
- -96.90%
- 52-wk range
- $0.37 – $19.11
Key statistics
Today's trading snapshot for EYPT: day range, open, previous close, volume and market cap.
- Day range
- $0.37 – $0.41
- Open
- $0.40
- Prev close
- $0.40
- Volume
- 7.3M
- Market cap
- $34.87M
- Shares out
- 86.21M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for EyePoint, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 12.36
- P/B
- 0.21
- P/FCF
- —
- ROE
- -184.4%
- ROA
- -134.4%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events EyePoint, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Business line exitOct 19, 2026
The Prioritization includes a plan to conclude the pivotal Phase 3 wet AMD clinical trials early and focus resources on the Company's late-stage program for DURAVYU™ in diabetic macular edema (DME).
- Investor presentationOct 19, 2026
Additionally, on October 19, 2026, the Company posted an updated investor presentation on its website at www.eyepoint.bio.
- Investor presentationSep 10, 2026
On September 10, 2026, EyePoint, Inc. posted an updated investor presentation on its website at www.eyepoint.bio. A copy of the presentation is filed herewith as Exhibit 99.1 and is incorporated by reference herein.
- Clinical trial resultsAug 17, 2026
On August 17, 2026, EyePoint, Inc. (the "Company") issued a press release announcing topline data for LUGANO, one of its pivotal Phase 3 clinical trials evaluating DURAVYU™ for wet age-related macular degeneration (wet AMD).
- Investor presentationAug 5, 2026
Also on August 5, 2026, the Company posted an updated investor presentation on its website at www.eyepoint.bio. A copy of the presentation is filed herewith as Exhibit 99.2 and is incorporated by reference herein.
Dividend history and stock splits
EyePoint, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-10Dec 9, 2020
EYPT short interest
How heavily EYPT is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 5.4
- Short interest
- 20.79M
- Avg volume
- 3.86M
As of · reported to FINRA twice monthly.
EYPT news
The latest news and headlines about EyePoint, Inc. Common Stock (EYPT).
- EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMDnegativeGlobeNewswire Inc.· Oct 19, 2026
- Here's Why You Should Add EYPT Stock to Your Portfolio NowneutralZacks Investment Research· Oct 15, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPTnegativeGlobeNewswire Inc.· Oct 6, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPTnegativeGlobeNewswire Inc.· Sep 8, 2026
- EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law FirmnegativeGlobeNewswire Inc.· Sep 4, 2026
Frequently asked questions
What is the EyePoint, Inc. Common Stock (EYPT) stock price today?
EyePoint, Inc. Common Stock (EYPT) is trading at $0.3700 (-8.53% on the day) as of 2:33:11 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is EyePoint, Inc. Common Stock?
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care.
What is the short interest in EYPT?
As of Sep 30, 2026, EYPT has 20.79M shares short and 5.4 days to cover.
What exchange is EYPT listed on?
EyePoint, Inc. Common Stock (EYPT) trades on Nasdaq in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.
Build with AI
Build an analysis of EYPT with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a EYPT analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.